4//SEC Filing
KING RICHARD 4
Accession 0001209191-18-039249
CIK 0001328143other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 4:47 PM ET
Size
5.4 KB
Accession
0001209191-18-039249
Insider Transaction Report
Form 4
KING RICHARD
Chief Operating Officer
Transactions
- Sale
Common Stock
2018-06-21$25.48/sh−2,501$63,725→ 48,856 total
Footnotes (3)
- [F1]Pursuant to the mandatory sale to cover withholding tax requirements of the issuer's equity incentive plan, the shares were sold to cover the tax obligation realized upon the vesting of restricted stock units.
- [F2]The shares were sold at prices ranging from $25.42 to $25.53. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Includes 696 shares purchased on 5/31/18 through the issuer's employee stock purchase plan.
Documents
Issuer
Adamas Pharmaceuticals Inc
CIK 0001328143
Entity typeother
Related Parties
1- filerCIK 0001013702
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 4:47 PM ET
- Size
- 5.4 KB